Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor? - KIVIRID

Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?

Authors: Hans Slabbynck, Johan Clukers, Daniella Galdermans

Published: 2020-01-30

DOI: 10.1183/13993003.02028-2019

Source: Full article

Abstract

No abstract found.